ZATYMRA

Welcome to the Brand page for “ZATYMRA”, which is offered here for Pharmaceutical and veterinary preparations for use in the treatment and prevention of cancer, metastases, oncological and cell-proliferative diseases, disorders and conditions as well as for the treatment and prevention of complications associated with cancer; pharmaceutical preparations comprising platinum agents for use in the treatment and prevention of cancer and complications associated therewith;.

Its status is currently believed to be active. Its class is unavailable. “ZATYMRA” is believed to be currently owned by “GPC Biotech AG”.